DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,272 | -43.8% | 335,885 | -37.8% | 0.04% | -33.9% |
| Q2 2023 | $7,608 | +13.3% | 540,316 | +24.3% | 0.06% | +10.7% |
| Q1 2023 | $6,716 | -29.3% | 434,670 | -25.0% | 0.06% | -59.4% |
| Q4 2022 | $9,501 | -99.8% | 579,654 | +87.6% | 0.14% | +84.0% |
| Q3 2022 | $5,716,000 | +20.7% | 308,969 | -14.2% | 0.08% | +29.3% |
| Q2 2022 | $4,734,000 | +84.3% | 360,015 | +29.9% | 0.06% | +81.2% |
| Q1 2022 | $2,569,000 | +230.6% | 277,155 | +1936.7% | 0.03% | +300.0% |
| Q4 2020 | $777,000 | – | 13,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |